Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Oncologists Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the market.
The global oncologists market is expected to grow from $54.37 billion in 2022 to $60.36 billion in 2023 at a compound annual growth rate (CAGR) of 12.80%. The oncologists market is expected to reach $84.77 billion in 2027 at a CAGR of 8.86%.
Major players in the oncologists market are Abramson Cancer Center, MD Anderson Cancer Center, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charite University Hospital, GE Healthcare, F Hoffmann La Roche AG, Pfizer Inc, Bayer AG, Merck & Co Inc, Aegerion Pharmaceuticals Inc, Abbvie Inc, Amgen Inc, and Takeda Pharmaceuticals USA Inc.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Oncologists refer to a type of healthcare practitioner who is specialized in the diagnosis and treatment of cancer. Oncologists evaluate the patient, diagnose the cancer, and recommend treatments. They are employed in the treatment and care of cancer patients.
The main cancer diagnostics and treatment of oncologists are cancer diagnostics and cancer treatment. Cancer diagnostics refers to testing procedures that confirm the presence of cancer and identify the tumor type. The indications such as lungs cancer, colorectal cancer, breast cancer, liver cancer, bladder cancer, head and neck cancer, prostate cancer with the end use included hospitals, diagnostic laboratories, diagnostic imaging centers, specialty clinics, academia and others.
New innovations are a key trend gaining popularity in the oncologists' market. Major companies operating in the oncology market are focused on developing new digital solutions to strengthen their position. For instance, in December 2021, The Roche Group, the Switzerland-based, biotech company and pioneer in pharmaceuticals and diagnostics, will be launching its latest digital solution, "Navify Oncology Hub." The new solution is expected to simplify clinical workflow and enhance the decision support provided to oncology care teams and oncologists. The solution helps to aggregate and organize fragmented patient data across an institution's IT systems.
In April 2021, Siemens Healthineers AG, a Germany-based leader in medical technology and provider of healthcare, acquired Varian Medical Systems, Inc. for an undisclosed amount. Through this acquisition, combined resources will enable the establishment of support for cancer patients and all major clinical pathways. This acquisition is expected to enable us to fight against increasing cancer rates by addressing the need for personalized, data-driven diagnosis and cancer care. Varian Medical Systems, Inc., is a US-based provider of radiation oncology software and treatments.
The countries covered in the oncologists market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The growing prevalence of cancer is expected to propel the oncologists' market going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts.
The prevalence of cancer refers to the number of new cancer cases that arise in a specified population in a given period of time. Oncologists refer to healthcare practitioners who are specialized in the diagnosis and treatment of cancer. They are involved in examining the patient, diagnosing the cancer, and identifying treatment options. or instance, according to the 2021 American Cancer Society report, 1.8 million new cases of cancer diagnosed were diagnosed in 2020.
Furthermore, the National Cancer Institute, a US-based government organisation that is a part of the National Institutes of Health, reported in September 2020 that 1,806,590 new cancer cases were registered, which indicated a 43% increase from 2019. Therefore, the growing prevalence of cancer is driving the oncologists' market.
The oncologists market includes revenues earned by entities by providing diagnoses and treats cancer, radiation oncologists and surgical oncologists. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value (USD) in 2023 | $60.36 billion |
| Forecasted Market Value (USD) by 2027 | $84.77 billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
Key Topics Covered:
1. Executive Summary
2. Oncologists Market Characteristics
3. Oncologists Market Trends And Strategies
4. Oncologists Market - Macro Economic Scenario
4.1. COVID-19 Impact On Oncologists Market
4.2. Ukraine-Russia War Impact On Oncologists Market
4.3. Impact Of High Inflation On Oncologists Market
5. Oncologists Market Size And Growth
5.1. Global Oncologists Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Oncologists Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Oncologists Market Segmentation
6.1. Global Oncologists Market, Segmentation By Cancer Diagnostics and Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Cancer Diagnostics
- Cancer Treatment
6.2. Global Oncologists Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head and Neck Cancer
- Prostate Cancer
- Other Indications
6.3. Global Oncologists Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Specialty Clinics
- Academia
- Other End Uses
7. Oncologists Market Regional And Country Analysis
7.1. Global Oncologists Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Oncologists Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/1gp750
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
